Skip to main content
. 2020 May 19;20:302. doi: 10.1186/s12884-020-02997-7

Table 5.

Associations between preeclampsia and maternal plasma TMAO concentration at the time of delivery

PE type Quartile for TMAO concentration in the third trimester (μg/m3) p for trend Per 50 μg/m3 increment
Q1 (< 86.30) Q2 (86.30- < 138.60) Q3 (138.60- < 207.04) Q4 (≥207.04)
PE
 Case / Control 8/ 57 22/ 45 14/ 52 22/ 44
 OR (95%CI) Reference 3.48 (1.42, 8.56) 1.92 (0.74, 4.94) 3.56 (1.45, 8.76) 0.033 1.23 (1.09, 1.37)
 ORaadj (95%CI) Reference 3.62 (1.39, 9.43) 2.10 (0.80, 5.55) 4.25 (1.62, 11.10) 0.018 1.24 (1.09, 1.40)
EOPE
 Case / Control 1/ 57 5/ 45 1/ 52 10/ 44
 OR (95%CI) Reference 6.33 (0.71, 56.16) 1.10 (0.07, 17.98) 12.96 (1.60, 105.04) 0.008 1.59 (1.29, 1.96)
 ORaadj (95%CI) Reference 5.76 (0.64, 52.27) 1.15 (0.09, 14.88) 14.86 (1.66, 129.85) 0.010 1.62 (1.29, 2.03)
LOPE
 Case / Control 7/ 57 17/ 45 13/ 52 12/ 44
 OR (95%CI) Reference 3.08 (1.17, 8.06) 2.04 (0.75, 5.49) 2.22 (0.81, 6.11) 0.273 1.12 (0.99, 1.27)
 ORaadj (95%CI) Reference 3.41 (1.21, 9.56) 2.23 (0.80, 6.22) 2.70 (0.93, 7.85) 0.190 1.12 (0.98, 1.28)
Mild PE
 Case / Control 7/ 57 13/ 45 10/ 52 11/ 44
 OR (95%CI) Reference 2.35 (0.87, 6.39) 1.57 (0.56, 4.41) 2.04 (0.73, 5.68) 0.319 1.14 (1.00, 1.31)
 ORaadj (95%CI) Reference 2.16 (0.75, 6.24) 1.83 (0.62, 5.39) 2.61 (0.87, 7.83) 0.184 1.16 (1.00, 1.35)
Severe PE
 Case / Control 1/ 57 9/ 45 4/ 52 11/ 44
 OR (95%CI) Reference 11.39 (1.39, 93.27) 4.39 (0.48, 40.50) 14.25 (1.77, 114.59) 0.015 1.40 (1.18, 1.67)
 ORaadj (95%CI) Reference 12.25 (1.41, 106.65) 4.42 (0.48, 40.92) 14.37 (1.74, 118.77) 0.019 1.41 (1.17, 1.70)

a Adjusted for year of education, pre-pregnancy BMI, smoking during pregnancy, fetal gender;

Abbreviation: TMAO trimethylamine-N-oxide; PE preeclampsia; EOPE early onset preeclampsia; LOPE late onset preeclampsia; OR odds ratio; CI confidence interval